Fabric Genomics (formerly Omicia)

Fabric Genomics is making genomics-driven precision medicine a reality. We provide clinical decision support software that enables clinical labs, hospital systems and country-sequencing programs to gain actionable genomic insights, resulting in faster and more accurate diagnoses and reduced turnaround time. Fabric’s end-to-end genomic analysis platform incorporates proven AI algorithms, and has applications in both hereditary disease and oncology. Headquartered in Oakland, California, Fabric Genomics was founded by industry veterans and innovators with a deep understanding of bioinformatics, large-scale genomics and clinical diagnostics.

Fabric Genomics (formerly Omicia) headquartered in United States, North America, operates in the Biotechnology, Artificial Intelligence (AI), Health Care, Genetics, Bioinformatics, Precision Medicine sector. The company focuses on Biotechnology and has secured $3.6B in funding across 120 round(s). With a team of 11-50 employees, Fabric Genomics (formerly Omicia) is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Fabric Genomics (formerly Omicia), raised $6.8M. Discover more about their projects, partnerships, and impact on our platform.